![Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/09/ced-pexels-13091435.jpg?resize=150%2C150&ssl=1 "Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z] 2")
Racial Diversity in Cannabis Use Disorder Research: A Systematic Review
Racial diversity cannabis use disorder research reveals significant underrepresentation of people of color in clinical trials. This gap impacts the development of culturally adapted treatments for cannabis use disorder. Addressing these disparities is…
A Randomized Trial on Topical Cannabis Balms for AIMSS
This randomized trial evaluates topical cannabis balms AIMSS clinical trial feasibility and tolerability in postmenopausal breast cancer survivors. The study compares CBD and THC balms for joint pain relief. Results provide preliminary insights into…
Vaporized Cannabis vs Placebo for Acute Migraine: A Randomized Trial
This randomized trial evaluates vaporized cannabis acute migraine treatment. The THC+CBD combination showed significant pain relief compared to placebo. These findings support cannabis as a potential option for acute migraine care.
Clinical Research on CBD’s Impact on Hippocampal Glutamate in Psychosis
CBD hippocampal glutamate modulation psychosis research reveals how a single dose of CBD affects brain activity during memory tasks. This modulation may normalize disrupted glutamate signaling in early psychosis. These findings highlight CBD’s potential…
Topical Cannabis for AIMSS: Medical Cannabis Evidence
This study evaluates topical cannabinoid application feasibility in postmenopausal breast cancer patients with AIMSS. The trial found topical cannabis balms to be well tolerated. These results support further research on topical cannabinoid application…
Cannabidiol Drug Interactions: Clinical Evidence Review
Cannabidiol drug interactions clinical evidence highlights CBD's potential to interact with multiple drug classes, especially opioids. Careful medication review is essential before starting CBD in patients on complex regimens. Clinicians should treat CBD…
Maternal Cannabis & Autism/ADHD Risk: Clinical Evidence
Maternal cannabis use in pregnancy risks research indicates a modestly elevated risk for autism spectrum disorder and ADHD in children. Cannabis compounds cross the placental barrier and may affect fetal brain development. These findings support caution…
Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State fNIRS
Functional near-infrared spectroscopy THC impairment detection offers an objective approach to measuring cannabis intoxication. This technology outperforms traditional field sobriety tests in accuracy. It provides new insights into brain activity changes…
Selective Personality-Targeted Intervention and Substance Use Escalation in Adolescents
Selective prevention programs focus on adolescents with personality risk factors to reduce substance use escalation. This approach targets traits like anxiety sensitivity and impulsivity. Such programs offer promising strategies for early intervention in…
Therapeutic Use of Cannabis Derivatives for Autism: Systematic Review
The therapeutic cannabis autism systematic review evaluates randomized clinical trials on cannabis derivatives for autism spectrum disorder. Evidence suggests potential benefits but remains limited by low certainty and methodological variability. Larger,…